![]() |
Volumn 116, Issue 3, 2004, Pages 45-48
|
Changing the face of pain management: Mechanism-based treatment most likely to succeed
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIEMETIC AGENT;
BACLOFEN;
BUPIVACAINE;
CHLORPROMAZINE;
CORTICOSTEROID;
CYCLOOXYGENASE 2 INHIBITOR;
LIDOCAINE;
LOCAL ANESTHETIC AGENT;
MUSCLE RELAXANT AGENT;
NEUROLEPTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
OCTACAINE;
OPIATE DERIVATIVE;
ORPHENADRINE CITRATE;
SPASMOLYTIC AGENT;
TIZANIDINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADULT;
ARM;
BACKACHE;
CASE REPORT;
CONFERENCE PAPER;
CONSTIPATION;
CORTICOSTEROID THERAPY;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
EDEMA;
HUMAN;
INTERVERTEBRAL DISK HERNIA;
MALE;
NAUSEA;
NECK INJURY;
NECK PAIN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHYSIOTHERAPY;
PRURITUS;
SCAPULA;
SEIZURE;
SIDE EFFECT;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VERTEBRAL CANAL STENOSIS;
|
EID: 4644373233
PISSN: 00325481
EISSN: None
Source Type: Journal
DOI: 10.3810/pgm.2004.09.1582 Document Type: Conference Paper |
Times cited : (6)
|
References (6)
|